Is BPC-157 Legal in California? Federal Rules, State Framework, and How to Get It

Is BPC-157 an approved drug? No.

BPC-157 is a synthetic peptide of 15 amino acids [1]. No FDA-approved drug contains it, there is no US Pharmacopeia or National Formulary monograph for it, and FDA's July 2026 review found no approved product containing it in any country it searched [1].

Websites sell BPC-157 as capsules, injections, oral sprays and nasal sprays, some labeled "for research purposes only and not for human or veterinary use" [1]. Those are not approved drugs [1].

What the federal lists say

FDA's list of bulk substances nominated for use by state-licensed pharmacies and physicians, updated May 14, 2026, has three categories. BPC-157 is in none of them [2]. It sat in category 2, FDA's significant-safety-risk group, from September 2023 until April 22, 2026, then moved to a nominated-but-withdrawn table because the groups that nominated it withdrew [5]. Removal was not a finding of safety. FDA's stated concerns remain on its site, including possible immunogenicity for certain routes of administration and limited safety information [5]. BPC-157 is also not on FDA's list for outsourcing facilities, updated March 21, 2025 [6].

On July 23, 2026, FDA's Pharmacy Compounding Advisory Committee voted in favor of adding BPC-157 to the pharmacy bulks list, against FDA staff's recommendation [7][1]. The vote is advice only, and BPC-157 is not on the list [7][3].

The October 2026 draft HHS policy

The draft policy covers six peptides, including BPC-157, and applies while FDA's list is developed through rulemaking. Its conditions for BPC-157 include [3]:

• BPC-157 acetate only, as a single active ingredient, in subcutaneous, intramuscular, oral or topical forms.
• A bulk substance from an FDA-registered manufacturer with a valid certificate of analysis.
• A patient-specific prescription.
• A label reading "This is a compounded drug product. Not for resale."
• Serious adverse events and quality problems reported to FDA MedWatch.

The notice says it "does not establish any rights for any person and is not binding on HHS or the public," and HHS may revisit it [3]. It names state-licensed pharmacies, federal facilities and licensed physicians, not outsourcing facilities [3]. Compounded drugs are not FDA-approved, so FDA does not review their safety, effectiveness or quality before marketing [3].

Does California have its own BPC-157 rules?

Federal enforcement discretion does not grant California permission. The federal rules do not establish whether California law allows a particular pharmacy or clinician to compound or dispense BPC-157 [3].

Athletes

WADA's Prohibited List names BPC-157 under S0, non-approved substances, and prohibits it at all times, in and out of competition; the 2026 List has been in force since January 1, 2026 [8].